Merit Financial Statements From 2010 to 2026

MMSI Stock  USD 75.48  1.02  1.33%   
Merit Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Merit Medical's valuation are provided below:
Gross Profit
738.3 M
Profit Margin
0.0848
Market Capitalization
4.6 B
Enterprise Value Revenue
3.3865
Revenue
1.5 B
We have found one hundred twenty available fundamental ratios for Merit Medical, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of Merit Medical last-minute fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The Merit Medical's current Market Cap is estimated to increase to about 3.8 B. The Merit Medical's current Enterprise Value is estimated to increase to about 4 B

Merit Medical Total Revenue

1.59 Billion

Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 141.4 M, Interest Expense of 27.8 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 2.74, Dividend Yield of 0.0 or PTB Ratio of 3.62. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
  
Build AI portfolio with Merit Stock
Check out the analysis of Merit Medical Correlation against competitors.

Merit Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.8 B2.7 B1.4 B
Slightly volatile
Short and Long Term Debt Total943.1 M898.2 M415.5 M
Slightly volatile
Other Current Liabilities171.6 M163.4 M81.8 M
Slightly volatile
Total Current Liabilities251.8 M239.8 M144.7 M
Slightly volatile
Total Stockholder Equity1.7 B1.6 B828 M
Slightly volatile
Property Plant And Equipment Net541.8 M516 M343.1 M
Slightly volatile
Net Debt472.2 M449.7 M282.1 M
Slightly volatile
Non Current Assets Total1.7 B1.6 B950.5 M
Slightly volatile
Net Receivables234.8 M223.6 M130.2 M
Slightly volatile
Common Stock Shares Outstanding40.9 M60.5 M48.3 M
Slightly volatile
Liabilities And Stockholders Equity2.8 B2.7 B1.4 B
Slightly volatile
Non Current Liabilities Total904.9 M861.9 M443 M
Slightly volatile
Inventory350.4 M333.7 M183.2 M
Slightly volatile
Other Current Assets36.1 M34.3 M18.3 M
Slightly volatile
Total Liabilities1.2 B1.1 B587.7 M
Slightly volatile
Property Plant And Equipment Gross937.1 M892.4 M455.2 M
Slightly volatile
Total Current Assets1.1 BB465.2 M
Slightly volatile
Short Term Debt11 M10.9 M16 M
Slightly volatile
Intangible Assets564.5 M537.7 M277.7 M
Slightly volatile
Cash470.9 M448.5 M133.5 M
Slightly volatile
Cash And Short Term Investments470.9 M448.5 M133.6 M
Slightly volatile
Accounts Payable63.6 M60.6 M44.7 M
Slightly volatile
Non Currrent Assets Other34.2 M32.6 M24.5 M
Slightly volatile
Common Stock Total Equity815.3 M776.5 M441.4 M
Slightly volatile
Common Stock802.1 M763.9 M439.3 M
Slightly volatile
Other Liabilities35.4 M60.3 M52.2 M
Slightly volatile
Other Assets26.4 M44.7 M38.3 M
Slightly volatile
Long Term Debt770.7 M734 M360.8 M
Slightly volatile
Good Will532.2 M506.8 M288.4 M
Slightly volatile
Property Plant Equipment462.4 M440.4 M319 M
Slightly volatile
Current Deferred Revenue3.9 M4.6 M3.2 M
Slightly volatile
Net Tangible Assets614.3 M585 M290.1 M
Slightly volatile
Long Term Debt Total281.4 M214.8 M231.1 M
Slightly volatile
Long Term Investments14.6 M28.7 M11.2 M
Slightly volatile
Non Current Liabilities Other11.9 M12.6 M24.8 M
Pretty Stable
Deferred Long Term Asset Charges1.9 M2.1 M2.3 M
Pretty Stable
Short and Long Term Debt9.4 M10.1 M11.1 M
Very volatile
Net Invested Capital1.7 B2.3 B1.3 B
Slightly volatile
Net Working Capital481.5 M800.4 M342.6 M
Slightly volatile
Capital Stock713.2 M763.9 M615.9 M
Slightly volatile
Capital Lease Obligations60.8 M87.5 M79.5 M
Slightly volatile

Merit Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization141.4 M134.6 M70.9 M
Slightly volatile
Total Revenue1.6 B1.5 B845.7 M
Slightly volatile
Other Operating Expenses1.4 B1.3 B778.4 M
Slightly volatile
Cost Of Revenue816.5 M777.6 M459.4 M
Slightly volatile
Total Operating Expenses581.2 M553.5 M319 M
Slightly volatile
Research Development102.2 M97.4 M56.2 M
Slightly volatile
Selling General Administrative478 M455.2 M256.5 M
Slightly volatile
Non Recurring11.7 M10.2 M12.1 M
Slightly volatile
Interest Income15.8 M15.1 M5.9 M
Slightly volatile
Reconciled Depreciation106.3 M134.6 M79.5 M
Slightly volatile

Merit Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow397.7 M378.8 M103.4 M
Slightly volatile
Depreciation141.4 M134.6 M71 M
Slightly volatile
Capital Expenditures85.8 M81.7 M51.1 M
Slightly volatile
Total Cash From Operating Activities312.2 M297.4 M114 M
Slightly volatile
End Period Cash Flow471 M448.5 M133.8 M
Slightly volatile
Stock Based Compensation45.6 M43.5 M12.8 M
Slightly volatile
Change To Netincome30.8 M45.7 M39.8 M
Slightly volatile
Issuance Of Capital Stock36.3 M28.2 M124.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.743.43972.9039
Very volatile
PTB Ratio3.623.29123.2308
Very volatile
Days Sales Outstanding64.4453.841157.5715
Very volatile
Book Value Per Share28.1226.780915.532
Slightly volatile
Operating Cash Flow Per Share5.285.02672.1066
Slightly volatile
Average PayablesMM4.5 M
Slightly volatile
Stock Based Compensation To Revenue0.03010.02870.0113
Slightly volatile
Capex To Depreciation0.580.60691.2967
Slightly volatile
PB Ratio3.623.29123.2308
Very volatile
EV To Sales2.933.73633.2392
Very volatile
Inventory Turnover2.182.33032.7834
Slightly volatile
Days Of Inventory On Hand158157137
Slightly volatile
Payables Turnover8.0212.84279.3474
Slightly volatile
Average Inventory15.9 M18 M19.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.04490.06420.0661
Slightly volatile
Capex To Revenue0.09710.05390.0874
Slightly volatile
Cash Per Share7.967.58152.3337
Slightly volatile
POCF Ratio35.0717.534341.0984
Slightly volatile
Capex To Operating Cash Flow0.260.27481.1452
Slightly volatile
Days Payables Outstanding44.4328.420944.6154
Slightly volatile
EV To Operating Cash Flow18.0919.046642.87
Slightly volatile
Intangibles To Total Assets0.410.38890.3795
Slightly volatile
Current Ratio2.514.33822.8317
Slightly volatile
Tangible Book Value Per Share9.589.12494.9248
Slightly volatile
Receivables Turnover5.126.77926.3871
Pretty Stable
Graham Number37.9936.176817.5291
Slightly volatile
Shareholders Equity Per Share28.1226.780915.532
Slightly volatile
Debt To Equity0.60.5670.4731
Slightly volatile
Capex Per Share1.451.38131.0243
Very volatile
Average Receivables11.9 M14.3 M15.5 M
Slightly volatile
Revenue Per Share26.9125.624715.9549
Slightly volatile
Interest Debt Per Share16.4115.63097.9413
Slightly volatile
Debt To Assets0.350.33440.2714
Slightly volatile
Short Term Coverage Ratios29.8731.4410.6553
Slightly volatile
Operating Cycle223210194
Slightly volatile
Price Book Value Ratio3.623.29123.2308
Very volatile
Days Of Payables Outstanding44.4328.420944.6154
Slightly volatile
Price To Operating Cash Flows Ratio35.0717.534341.0984
Slightly volatile
Ebt Per Ebit0.880.92541.3034
Very volatile
Company Equity Multiplier1.261.69531.672
Very volatile
Long Term Debt To Capitalization0.360.33850.2849
Slightly volatile
Total Debt To Capitalization0.380.36180.3111
Slightly volatile
Debt Equity Ratio0.60.5670.4731
Slightly volatile
Quick Ratio3.092.94641.7839
Slightly volatile
Dividend Paid And Capex Coverage Ratio3.823.63912.2771
Slightly volatile
Net Income Per E B T0.620.75170.88
Very volatile
Cash Ratio1.961.87060.7016
Slightly volatile
Cash Conversion Cycle181182158
Slightly volatile
Operating Cash Flow Sales Ratio0.210.19620.1196
Slightly volatile
Days Of Inventory Outstanding158157137
Slightly volatile
Days Of Sales Outstanding64.4453.841157.5715
Very volatile
Price To Book Ratio3.623.29123.2308
Very volatile
Fixed Asset Turnover3.212.93782.4302
Slightly volatile
Capital Expenditure Coverage Ratio3.823.63912.2771
Slightly volatile
Price Cash Flow Ratio35.0717.534341.0984
Slightly volatile
Debt Ratio0.350.33440.2714
Slightly volatile
Price Sales Ratio2.743.43972.9039
Very volatile
Asset Turnover1.030.56440.6622
Pretty Stable
Price Fair Value3.623.29123.2308
Very volatile

Merit Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.8 B3.6 B2.6 B
Slightly volatile
Enterprise ValueB3.8 B3.2 B
Slightly volatile

Merit Fundamental Market Drivers

Forward Price Earnings19.0114
Cash And Short Term Investments448.5 M

Merit Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue4.6 M3.9 M
Total Revenue1.5 B1.6 B
Cost Of Revenue777.6 M816.5 M
Stock Based Compensation To Revenue 0.03  0.03 
Research And Ddevelopement To Revenue 0.06  0.04 
Capex To Revenue 0.05  0.10 
Revenue Per Share 25.62  26.91 
Ebit Per Revenue 0.12  0.06 

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Check out the analysis of Merit Medical Correlation against competitors.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is there potential for Health Care Equipment & Supplies market expansion? Will Merit introduce new products? Factors like these will boost the valuation of Merit Medical. Expected growth trajectory for Merit significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.388
Earnings Share
1.95
Revenue Per Share
25.625
Quarterly Revenue Growth
0.109
Return On Assets
0.0475
Investors evaluate Merit Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Merit Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Merit Medical's market price to deviate significantly from intrinsic value.
Understanding that Merit Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merit Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Merit Medical's market price signifies the transaction level at which participants voluntarily complete trades.